704 related articles for article (PubMed ID: 26269223)
41. Poor renal outcome of antineutrophil cytoplasmic antibody negative Pauci-immune glomerulonephritis in Taiwanese.
Hung PH; Chiu YL; Lin WC; Chiang WC; Chen YM; Lin SL; Wu KD; Tsai TJ
J Formos Med Assoc; 2006 Oct; 105(10):804-12. PubMed ID: 17000453
[TBL] [Abstract][Full Text] [Related]
42. Clinical characteristics and outcome of pauci-immune glomerulonephritis in African Americans.
Geetha D; Poulton CJ; Hu Y; Seo P; McGregor JA; Falk RJ; Hogan SL
Semin Arthritis Rheum; 2014 Jun; 43(6):778-83. PubMed ID: 24387818
[TBL] [Abstract][Full Text] [Related]
43. Clinical spectrum associated with ANCA of defined antigen specificities in 98 selected patients.
Geffriaud-Ricouard C; Noël LH; Chauveau D; Houhou S; Grünfeld JP; Lesavre P
Clin Nephrol; 1993 Mar; 39(3):125-36. PubMed ID: 7681736
[TBL] [Abstract][Full Text] [Related]
44. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization.
Hagen EC; Daha MR; Hermans J; Andrassy K; Csernok E; Gaskin G; Lesavre P; Lüdemann J; Rasmussen N; Sinico RA; Wiik A; van der Woude FJ
Kidney Int; 1998 Mar; 53(3):743-53. PubMed ID: 9507222
[TBL] [Abstract][Full Text] [Related]
45. Complement in ANCA-associated glomerulonephritis.
Hilhorst M; van Paassen P; van Rie H; Bijnens N; Heerings-Rewinkel P; van Breda Vriesman P; Cohen Tervaert JW;
Nephrol Dial Transplant; 2017 Aug; 32(8):1302-1313. PubMed ID: 26275893
[TBL] [Abstract][Full Text] [Related]
46. Pauci-immune crescentic glomerulonephritis superimposed on diabetic glomerulosclerosis.
Nasr SH; D'Agati VD; Said SM; Stokes MB; Appel GB; Valeri AM; Markowitz GS
Clin J Am Soc Nephrol; 2008 Sep; 3(5):1282-8. PubMed ID: 18508945
[TBL] [Abstract][Full Text] [Related]
47. Increase of Antimyeloperoxidase Antineutrophil Cytoplasmic Antibody (ANCA) in Patients with Renal ANCA-associated Vasculitis: Association with Risk to Relapse.
Yamaguchi M; Ando M; Kato S; Katsuno T; Kato N; Kosugi T; Sato W; Tsuboi N; Yasuda Y; Mizuno M; Ito Y; Matsuo S; Maruyama S
J Rheumatol; 2015 Oct; 42(10):1853-60. PubMed ID: 26373560
[TBL] [Abstract][Full Text] [Related]
48. Clinical course and outcome predictors in pauci-immune ANCA-positive renal-limited vasculitis.
Rupcić V; Jakić M; Rupcić V; Vizjak V; Fijacko M
Acta Clin Croat; 2011 Dec; 50(4):475-83. PubMed ID: 22649876
[TBL] [Abstract][Full Text] [Related]
49. Poor renal outcomes in patients with anti-neutrophil cytoplasmic antibody-associated crescentic glomerulonephritis and normal renal function at diagnosis.
Hanaoka H; Ota Y; Takeuchi T; Kuwana M
Clin Rheumatol; 2016 Feb; 35(2):495-500. PubMed ID: 26742758
[TBL] [Abstract][Full Text] [Related]
50. Etiology and Outcome of Crescentic Glomerulonephritis From a Single Center in China: A 10-Year Review.
Chen S; Tang Z; Xiang H; Li X; Chen H; Zhang H; Hu W; Zeng C; Liu Z
Am J Kidney Dis; 2016 Mar; 67(3):376-83. PubMed ID: 26388283
[TBL] [Abstract][Full Text] [Related]
51. ANCA-associated crescentic glomerulonephritis with mesangial IgA deposits.
Haas M; Jafri J; Bartosh SM; Karp SL; Adler SG; Meehan SM
Am J Kidney Dis; 2000 Oct; 36(4):709-18. PubMed ID: 11007672
[TBL] [Abstract][Full Text] [Related]
52. ANCA-associated crescentic glomerulonephritis with immune complex deposits.
Sumida K; Ubara Y; Nomura K; Hoshino J; Suwabe T; Hiramatsu R; Hasegawa E; Hayami N; Yamanouchi M; Sawa N; Takemoto F; Takaichi K; Ohashi K
Clin Nephrol; 2012 Jun; 77(6):454-60. PubMed ID: 22595387
[TBL] [Abstract][Full Text] [Related]
53. [Kidney injury molecules (KIM-1, MCP-1) and type IV collagen in the assessment of activity of antineutrophil cytoplasmic antibody-associated glomerulonephritis].
Bulanov NM; Serova AG; Kuznetsova EI; Bulanova ML; Novikov PI; Kozlovskaya LV; Moiseev SV
Ter Arkh; 2017; 89(6):48-55. PubMed ID: 28745689
[TBL] [Abstract][Full Text] [Related]
54. Glomerular C3d as a novel prognostic marker for renal vasculitis.
Villacorta J; Diaz-Crespo F; Acevedo M; Guerrero C; Campos-Martin Y; García-Díaz E; Mollejo M; Fernandez-Juarez G
Hum Pathol; 2016 Oct; 56():31-9. PubMed ID: 27257040
[TBL] [Abstract][Full Text] [Related]
55. Native and recombinant proteins to analyze auto-antibodies to myeloperoxidase in pauci-immune crescentic glomerulonephritis.
Boomsma MM; Stegeman CA; Oost-Kort WW; Kallenberg CG; Moguilevsky N; Limburg PC; Tervaert JW
J Immunol Methods; 2001 Aug; 254(1-2):47-58. PubMed ID: 11406152
[TBL] [Abstract][Full Text] [Related]
56. Significance of anti-neutrophil cytoplasmic antibodies in patients with pauci-immune crescentic glomerulonephritis.
Tang Z; Zhou H; Zhang S; Yao X; Hu W; Liu Z; Li L
Chin Med J (Engl); 1999 Dec; 112(12):1143-6. PubMed ID: 11721457
[TBL] [Abstract][Full Text] [Related]
57. Clinical and pathologic characteristics of pauci-immune anti-myeloperoxidase antibody associated glomerulonephritis with nephrotic range proteinuria.
Xu PC; Chen T; Gao S; Hu SY; Wei L; Yan TK
Ren Fail; 2018 Nov; 40(1):554-560. PubMed ID: 30278797
[TBL] [Abstract][Full Text] [Related]
58. Histopathologic and clinical predictors of kidney outcomes in ANCA-associated vasculitis.
Ford SL; Polkinghorne KR; Longano A; Dowling J; Dayan S; Kerr PG; Holdsworth SR; Kitching AR; Summers SA
Am J Kidney Dis; 2014 Feb; 63(2):227-35. PubMed ID: 24183110
[TBL] [Abstract][Full Text] [Related]
59. Clinicopathologic characteristics and outcomes of renal thrombotic microangiopathy in anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis.
Chen SF; Wang H; Huang YM; Li ZY; Wang SX; Yu F; Zhao MH; Chen M
Clin J Am Soc Nephrol; 2015 May; 10(5):750-8. PubMed ID: 25749534
[TBL] [Abstract][Full Text] [Related]
60. Clinicopathologic spectrum of crescentic glomerulonephritis: a hospital-based study.
Choudhury TA; Singh RG; ; Singh S; Singh TB; Rathore SS;
Saudi J Kidney Dis Transpl; 2014 May; 25(3):689-96. PubMed ID: 24821180
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
